Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14365/4821
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaşçı, Cengiz-
dc.contributor.authorDirican, Ahmet-
dc.contributor.authorSözbilen, Ethem Murat-
dc.contributor.authorPehlivan, F.S.-
dc.contributor.authorSerter, Selim-
dc.date.accessioned2023-09-11T17:53:49Z-
dc.date.available2023-09-11T17:53:49Z-
dc.date.issued2023-
dc.identifier.issn2146-1414-
dc.identifier.urihttps://doi.org/10.4274/mirt.galenos.2023.82712-
dc.identifier.urihttps://hdl.handle.net/20.500.14365/4821-
dc.description.abstractA 42-year-old female patient diagnosed with invasive ductal breast ca underwent18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) scan for staging, 1.5 cm diameter hypermetabolic lesion was observed in the lower inner quadrant of the right breast that was compatible with primary tumor [maximum standardized uptake value (SUVmax ): 10.5]. No pathological18F-FDG uptake was observed in lymph nodes whose fatty hilum was seen in the right axilla. However, in the left axilla and left deep axilla, hypermetabolic lymph nodes with a maksimum diameter of 19 mm and fatty hilum were observed (SUVmax: 8.0). In a detailed CT evaluation, these lymph nodes have thicker walls than the ones in the right axilla. The patient was questioned again and coronavirus disease-2019 (COVID-19) vaccination history (with BNT162b2, COVID-19 mRNA vaccine) was determined that was administrated to the left arm 5 days ago. Tru-cut biopsy was performed from the left aksillary lymph nodes and proved to be reactive lymphoid tissue and there was no primary or metastatic tumor in these axillary lymph node tissues. The patient was given neoadjuvant chemotherapy 4.5 months after the first18F-FDG PET/CT, and the second was performed for the treatment response evaluation. Significant regression was determined from the findings. The patient underwent right total mastechtomy. She was being followed up with adjuvant chemotherapy and radiotherapy. In conclusion, hypermetabolic lymph nodes in the axillas should be interrogated for vaccination in patients with breast cancer. Hypermetabolic lymph nodes observed on the same side of the vaccinated arm in the 18 F-FDG PET/CT scan may be related to vaccine-induced reactive lymph node enlargement. Lymph node metastasis may be excluded, especially if there are hypermetabolic lymph nodes with preserved fatty hilum in the contralateral axilla on the same side as the vaccinated arm. Active lymph nodes reactive to the vaccine become inactive after a while. © 2023 by the Turkish Society of Nuclear Medicine.en_US
dc.language.isoenen_US
dc.publisherGalenos Publishing Houseen_US
dc.relation.ispartofMolecular Imaging and Radionuclide Therapyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subject18F-FDG PET/CTen_US
dc.subjectAxillary lymph nodesen_US
dc.subjectbreast canceren_US
dc.subjectCOVID-19 vaccinationen_US
dc.subjectCD20 antigenen_US
dc.subjectCD3 antigenen_US
dc.subjectfluorodeoxyglucose f 18en_US
dc.subjecttozinameranen_US
dc.subjectadjuvant chemotherapyen_US
dc.subjectadulten_US
dc.subjectArticleen_US
dc.subjectaxillary lymph nodeen_US
dc.subjectcancer radiotherapyen_US
dc.subjectcancer stagingen_US
dc.subjectcase reporten_US
dc.subjectclinical articleen_US
dc.subjectcoronavirus disease 2019en_US
dc.subjectfemaleen_US
dc.subjecthumanen_US
dc.subjecthuman tissueen_US
dc.subjecthypermetabolismen_US
dc.subjectinvasive ductal breast carcinomaen_US
dc.subjectlymph node metastasisen_US
dc.subjectlymphadenopathyen_US
dc.subjectlymphoid tissueen_US
dc.subjectmaximum standardized uptake valueen_US
dc.subjectneoadjuvant chemotherapyen_US
dc.subjectpositron emission tomography-computed tomographyen_US
dc.subjectprimary tumoren_US
dc.subjectsimple mastectomyen_US
dc.subjecttreatment responseen_US
dc.subjecttumor volumeen_US
dc.subjectvaccinationen_US
dc.titleHypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Managementen_US
dc.title.alternativeMeme Kanseri Yönetiminde COVID-19 Aşısına Bağlı Hipermetabolik Aksiller Lenf Nodlarıen_US
dc.typeArticleen_US
dc.identifier.doi10.4274/mirt.galenos.2023.82712-
dc.identifier.scopus2-s2.0-85163630223en_US
dc.departmentİzmir Ekonomi Üniversitesien_US
dc.authorscopusid58406744300-
dc.authorscopusid57031594600-
dc.authorscopusid57202774848-
dc.authorscopusid23028660800-
dc.authorscopusid8514268900-
dc.identifier.volume32en_US
dc.identifier.issue2en_US
dc.identifier.startpage181en_US
dc.identifier.endpage185en_US
dc.institutionauthor-
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.trdizinid1185989en_US
dc.identifier.scopusqualityQ3-
item.grantfulltextopen-
item.openairetypeArticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextWith Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
crisitem.author.dept09.02. Internal Sciences-
crisitem.author.dept09.02. Internal Sciences-
crisitem.author.dept09.04. Surgical Sciences-
crisitem.author.dept09.02. Internal Sciences-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection
Files in This Item:
File SizeFormat 
MIRT-32-181-En.pdf807.67 kBAdobe PDFView/Open
Show simple item record



CORE Recommender

Page view(s)

100
checked on Nov 18, 2024

Download(s)

12
checked on Nov 18, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.